Back to SNDX
STATE STREET CORP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$123.7M
Q2 2026
Peak value
$123.7M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $108.4M |
| Q1 2024 | $114.7M |
| Q2 2024 | $74.4M |
| Q3 2024 | $72.6M |
| Q4 2024 | $51.8M |
| Q1 2025 | $48.8M |
| Q2 2025 | $32.2M |
| Q3 2025 | $59.3M |
| Q4 2025 | $96.6M |
| Q1 2026 | $103.5M |
| Q2 2026 | $123.7M |
| Q2 2026 | $123.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $123.7M | 5.66M | — | — |
| Q2 2026 | $123.7M | 5.66M | — | — |
| Q1 2026 | $103.5M | 4.43M | — | — |
| Q4 2025 | $96.6M | 4.60M | — | — |
| Q3 2025 | $59.3M | 3.85M | — | — |
| Q2 2025 | $32.2M | 3.44M | — | — |
| Q1 2025 | $48.8M | 3.97M | — | — |
| Q4 2024 | $51.8M | 3.92M | — | — |
| Q3 2024 | $72.6M | 3.77M | — | — |
| Q2 2024 | $74.4M | 3.62M | — | — |
| Q1 2024 | $114.7M | 4.82M | — | — |
| Q4 2023 | $108.4M | 5.02M | — | — |
Other funds holding SNDX
$118.9M
$116.1M
$114.2M
$114.2M
$111.4M
$83.3M